Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2014 16:01 ET | Source: Nanosphere, Inc.

Nanosphere, Inc. Announces the Closing of Common Stock Offering

NORTHBROOK, Ill., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the closing of...
October 22, 2014 09:00 ET | Source: Nanosphere, Inc.

Nanosphere Prices $20 Million Public Offering of Common Stock

NORTHBROOK, Ill., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
October 21, 2014 16:01 ET | Source: Nanosphere, Inc.

Nanosphere Announces Commencement of Public Offering of Common Stock; Preliminary Third Quarter 2014 Top Line Results

NORTHBROOK, Ill., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company" or "Nanosphere") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced...
October 13, 2014 08:00 ET | Source: Nanosphere, Inc.

FDA Clears Additional Viral Targets on Verigene Enteric Pathogens Test

NORTHBROOK, Ill., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has received 510(k)...
September 08, 2014 08:00 ET | Source: Nanosphere, Inc.

New Outcomes Data Presented at ICAAC 2014 Further Validates Clinical and Economic Utility of Nanosphere's Verigene Blood Culture Test

NORTHBROOK, Ill., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced that data from three outcomes studies...
September 04, 2014 16:01 ET | Source: Nanosphere, Inc.

Nanosphere Announces Review of Strategic Alternatives

NORTHBROOK, Ill., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that the Company has...
September 02, 2014 08:00 ET | Source: Nanosphere, Inc.

New Clinical and Economic Outcome Data for Verigene Blood Culture Test to Be Presented at ICAAC 2014

NORTHBROOK, Ill., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that three outcomes studies...
August 20, 2014 16:01 ET | Source: Nanosphere, Inc.

Nanosphere Appoints Kristopher Wood to Its Board of Directors

NORTHBROOK, Ill., Aug. 20, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the appointment of Kristopher...
August 06, 2014 16:01 ET | Source: Nanosphere, Inc.

Nanosphere Announces Second Quarter Financial and Operating Results

Corporate Highlights and Business Guidance: Added 37 new Verigene® System customer placements Achieved Q2 2014 revenues of $2.7 million, a 44% increase over Q2 2013 Increased...
July 23, 2014 08:00 ET | Source: Nanosphere, Inc.

Nanosphere to Release Second Quarter Results and Host Investor Conference Call on Wednesday, August 6, 2014

NORTHBROOK, Ill., July 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right